NewslettersCell Therapy NewsFoxp3 Confers Long-Term Efficacy of Chimeric Antigen Receptor-T Cells via Metabolic ReprogrammingBy Noshin Noorjahan - May 5, 202501242Scientists generated CAR-TFoxp3 cells by co-expressing Foxp3 with a third-generation CAR construct.[Cell Metabolism]Full ArticleGraphical Abstract